This is a working overview of reversed-phase HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-03-10 and is reviewed periodically as new material appears.
Regulatory status varies by jurisdiction, and the substance is frequently described as unapproved for therapeutic use. Some authorities classify it alongside prescription-only medicines or controlled categories, while others address it through general consumer protection rules. Analytical surveys have reported mismatches between label claims and measured content in products sold online, although the scope of such testing is limited. Whether these discrepancies are widespread remains an open question. Discussion in the literature therefore tends to combine chemistry, supply-chain observation and policy analysis.
The material is commonly handled as a lyophilized powder in sealed vials. The solid dissolves readily in water and in polar organic solvents, producing a clear solution after reconstitution. Light, heat and repeated freeze-thaw cycles are the concerns most often raised in handling guidance, because peptide bonds and the constrained ring can degrade. Working solutions are generally prepared fresh, and material left in solution is treated as less stable than the dry form. These properties shape how laboratories store and aliquot reference material.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Retention time supports identity, while the mass spectrum confirms the molecular weight of the intact peptide. Purity is frequently reported as a percentage of total peak area, a figure that depends on the wavelength, column and gradient used. Impurity profiling may also look for truncated sequences, oxidised forms and residual counterions. Amino acid analysis and peptide mapping provide orthogonal confirmation when required.
Analytical confirmation of identity relies on mass spectrometry, most often coupled to liquid chromatography. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and provides a purity estimate based on peak area. Electrospray ionization mass spectrometry then confirms the expected molecular mass, while tandem mass spectrometry can map the fragment sequence. For research-grade material, these two techniques together form the standard minimum. Purity figures reported by vendors are frequently not traceable to an independent laboratory.
Independent verification is central to quality control because the compound is not produced under pharmaceutical manufacturing standards. Third-party laboratories can measure purity, identity, residual solvents, and microbial contamination, though the scope of testing varies between services. Reported analyses of vendor samples have shown batch-to-batch variation in peptide content and the presence of truncated or oxidized species. How much of this variation reflects synthesis conditions versus storage and shipping is not well characterized. No harmonized reference standard exists for the material as sold.
Handling guidance for melanotan II follows general practice for small synthetic peptides rather than a product-specific monograph. Lyophilized powder is typically kept at minus twenty degrees Celsius or colder, protected from light and moisture, because warmth and humidity accelerate degradation. Once reconstituted, solutions are usually refrigerated and used within a short window, as hydrolysis and microbial growth both become concerns. Repeated freeze-thaw cycles are generally avoided. These conventions come from laboratory peptide chemistry and not from formal stability studies on this specific compound.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typically supplied as a lyophilized solid in a sealed vial |
| Solubility class | Soluble in water and polar organic solvents | Reconstituted solutions are generally clear |
| Typical storage temperature | -20 degrees Celsius or below, dry | Protect from light; avoid repeated freeze-thaw cycles |
| Common analytical methods | Reversed-phase HPLC-UV, LC-MS | Used for purity estimation and mass confirmation |
| Reported purity range | Area percentage above 95 percent | Reporting practice and acceptance limits differ by laboratory |
Identity testing for a cyclic peptide of this size usually relies on reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The mass spectrum confirms molecular weight, while the chromatographic trace indicates the proportion of related impurities. Tandem mass spectrometry can provide sequence-level information when fragmentation data are compared against a reference standard. Nuclear magnetic resonance is sometimes used to confirm the lactam bridge, although it requires more material and greater operator expertise than routine chromatographic methods.
Lyophilised peptide powder is comparatively stable when kept dry, cold and protected from light. Once dissolved, the molecule is exposed to hydrolysis, oxidation and microbial growth, and degradation accelerates at higher temperatures and in alkaline solution. Repeated freeze-thaw cycles concentrate solutes and promote aggregation. Handling guidance for research peptides commonly clusters around freezer temperatures for powder and short refrigerated use for reconstituted solutions, with pH control and sterile technique applied throughout.
Solid peptide kept dry at minus twenty degrees Celsius, shielded from light and moisture, is generally considered stable for extended periods. Solutions are divided into single-use aliquots and held at minus twenty or minus eighty degrees Celsius, because repeated freeze-thaw cycles promote aggregation and loss of material to container surfaces. Hydrolysis of the backbone and oxidation of tryptophan are the principal degradation routes in aqueous solution, and both accelerate at ambient temperature. Hygroscopic uptake after a vial is opened can also shift the actual mass weighed, which affects any concentration calculated from it.
Routine characterisation relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres, using a C18 column and a water-acetonitrile gradient containing trifluoroacetic acid. Electrospray ionisation mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidised by-products that co-elute poorly. Sequence and stereochemistry require additional work, such as peptide mapping or amino acid analysis, because a chromatographic purity figure alone does not distinguish a diastereomer from the target peptide. Independent testing of research-grade material frequently shows measured content below the stated label, so a certificate of analysis is best read together with the method that produced it.
Melanotan-2 is handled in the laboratory as a lyophilised powder that dissolves readily in water, dimethyl sulfoxide and dimethylformamide, with limited solubility in ethanol. Stock solutions prepared in an organic solvent often precipitate when diluted into aqueous buffer, so gradual dilution with mixing is standard practice. The peptide carries a tryptophan residue and a histidine residue, both sensitive to oxidation and to alkaline conditions. Working solutions are therefore kept near neutral to slightly acidic pH, protected from light, and consumed within the same working session whenever that is practical.
Such metabolic profiles can provide a complete overview of individual metabolite or pathway alterations, providing a more realistic depiction of disease phenotypes. This approach can then be applied to the prediction of response to a pharmaceutical compound by patients with a particular metabolic profile. Pharmacometabolomic analyses of drug response are often coupled or followed up with pharmacogenetics studies. Pharmacogenetics focuses on the identification of genetic variations (e.g. single-nucleotide polymorphisms) within patients that may contribute to altered drug responses and overall outcome of a certain treatment. The results of pharmacometabolomics analyses can act to "inform" or "direct" pharmacogenetic analyses by correlating aberrant metabolite concentrations or metabolic pathways to potential alterations at the genetic level. This concept has been established with two seminal publications from studies of antidepressants serotonin reuptake inhibitors where metabolic signatures were able to define pathway implicated in response to the antidepressant and that lead to identification of genetic variants within a key gene within highlighted pathway as being implicated in variation in response. These genetic variants were not identified through genetic analysis alone and hence illustrated how metabolomics can guide and inform genetic data.
M = the length of a number of links measured S = the number of links measured P = Pitch In industry, it is usual to monitor the movement of the chain tensioner (whether manual or automatic) or the exact length of a drive chain (one rule of thumb is to replace a roller chain which has elongated 3% on an adjustable drive or 1.5% on a fixed-center drive). A simpler method, particularly suitable for the cycle or motorcycle user, is to attempt to pull the chain away from the larger of the two sprockets, whilst ensuring the chain is taut. Any significant movement (e.g. making it possible to see through a gap) probably indicates a chain worn up to and beyond the limit. Sprocket damage will result if the problem is ignored. Sprocket wear cancels this effect, and may mask chain wear.
=== Hank Rizzoli === Hank Rizzoli (Ray Romano) is a photographer who is hired by the Braverman family for a family picture in season four. Sarah ultimately becomes Hank's assistant. While at first he disliked Sarah, the two begin a relationship that has problems as Sarah still has feelings for Mark Cyr. In season five, Hank begins a mentor-mentee relationship with Max and teaches him about photography. After spending time with Max, and reading a book about Asperger syndrome that Adam lent him (after one of Max's outbursts), Hank begins to realize that he shares many social qualities with Max and that he may have Asperger syndrome himself. Hank has a daughter, Ruby, from his previous marriage. When Amber is upset because Ryan York, her ex-fiancé, is involved in an accident, Hank offers to drive Amber the long distance to see Ryan. In season six, after Sarah and Hank move in together, Hank begins to bond with Amber and Drew. He helps Amber assemble her crib and asks Drew to be his best man. Hank and Sarah marry in the series finale.
=== History === Hemoglobin A1c was first separated from other forms of hemoglobin by Huisman and Meyering in 1958 using a chromatographic column. It was first characterized as a glycoprotein by Bookchin and Gallop in 1968. Its increase in diabetes was first described in 1969 by Samuel Rahbar and coworkers. The reactions leading to its formation were characterized by Bunn and coworkers in 1975. The use of hemoglobin A1c for monitoring the degree of control of glucose metabolism in diabetic patients was proposed in 1976 by Anthony Cerami, Ronald Koenig, and coworkers.
Sources: en.wikipedia.org
=== Regulation === PCP is a Schedule II substance in the US. The Administrative Controlled Substances Code Number (ACSCN) for PCP is 7471. Its manufacturing quota for 2014 was 19 grams (0.67 oz). It is a Schedule I drug by the Controlled Drugs and Substances act in Canada, a List I drug of the Opium Law in the Netherlands, and a Class A substance in the UK.
== Acquisition == In June 2013, Amgen offered to buy the shares of Onyx Pharmaceuticals for US$120 per share, sending the shares up by around 30% after the news was announced. Onyx announced on June 30, 2013, that it had rejected the unsolicited proffer from Amgen and its board of directors had subsequently authorized their financial advisers to contact other potential acquisition suitors. However after a series of efforts to secure a higher per-share price from other potential buyers repeatedly failed to materialize, the board reversed course and agreed to Amgen's original terms; the acquisition was formally announced on August 25, 2013.
=== Oxidative stress === Arsenic can cause oxidative stress through the formation of reactive oxygen species (ROS), and reactive nitrogen species (RNS). Reactive oxygen species are produced by the enzyme NADPH oxidase, which transfers electrons from NADPH to oxygen, synthesizing a superoxide, which is a reactive free radical. This superoxide can react to form hydrogen peroxide and a reactive oxygen species. The enzyme NADPH oxidase is able to generate more reactive oxygen species in the presence of arsenic, due to the subunit p22phox, which is responsible for the electron transfer, being upregulated by arsenic. The reactive oxygen species are capable of stressing the endoplasmic reticulum, which increases the amount of the unfolded protein response signals. This leads to inflammation, cell proliferation, and eventually to cell death. Another mechanism in which reactive oxygen species cause cell death would be through the cytoskeleton rearrangement, which affects the contractile proteins. The reactive nitrogen species arise once the reactive oxygen species destroy the mitochondria. This leads to the formation of the reactive nitrogen species, which are responsible for damaging DNA in arsenic poisoning. Mitochondrial damage is known to cause the release of reactive nitrogen species, due to the reaction between superoxides and nitric oxide (NO). Nitric oxide (NO) is a part of cell regulation, including cellular metabolism, growth, division and death. Nitric oxide (NO) reacts with reactive oxygen species to form peroxynitrite.
Sources: en.wikipedia.org
=== First generation === In-N-Out Burger's first location was opened in the Los Angeles suburb of Baldwin Park, California, in 1948 by the Snyders at the southwest corner of what is now the intersection of Interstate 10 and Francisquito Avenue. The restaurant was the first drive-thru hamburger stand in California, allowing drivers to place orders via a two-way speaker system. This was a new and unique idea, since in post-World War II California, carhops were used to take orders and serve food. In 1951, a second In-N-Out was opened in Covina, California, west of the intersection of Grand Avenue and Arrow Highway. The company remained a relatively small Southern California chain until the 1970s. The Snyders managed their first restaurants closely to ensure quality was maintained. The chain had 18 restaurants when Harry Snyder died in 1976, at the age of 63.
Noriega's relationship with the U.S. deteriorated further during the late 1980s, particularly after the U.S. began to suspect that Noriega was supporting other intelligence services. Hersh wrote in 1986 that U.S. intelligence officials suspected that Noriega was selling intelligence to the Cuban government of Fidel Castro; his report received widespread attention. Bob Woodward published a story about Noriega in The Washington Post soon afterward, going into even greater detail about Noriega's intelligence connections. Woodward and Hersh's reputations made certain that the stories were taken seriously. Spadafora had also informed the U.S. Drug Enforcement Administration (DEA) of some of his findings about Noriega's involvement in drug smuggling. Multiple U.S. agencies continued to investigate Noriega despite opposition from the Reagan administration. In 1988 Noriega was indicted by U.S. federal grand juries in courts in Miami and Tampa on charges of drug-trafficking. The indictment accused him of "turning Panama into a shipping platform for South American cocaine that was destined for the U.S., and allowing drug proceeds to be hidden in Panamanian banks". Soon afterward an army colonel and a few soldiers made an attempt to overthrow Noriega; their poorly planned effort was crushed within a day. The presidential election of May 1989 was marred by fraud and violence. Coalición para la Liberación Nacional (Coalition for National Liberation), a pro-military coalition led by the PRD, named Carlos Duque, a former business partner of Noriega, as its candidate.
== Directed panspermia == During the 1960s, Crick became concerned with the origins of the genetic code. In 1966, Crick took the place of Leslie Orgel at a meeting where Orgel was to talk about the origin of life. Crick speculated about possible stages by which an initially simple code with a few amino acid types might have evolved into the more complex code used by existing organisms. At that time, proteins were thought to be the only kind of enzyme, and ribozymes had not yet been identified. Many molecular biologists were puzzled by the problem of the origin of a protein replicating system that is as complex as that which exists in organisms currently inhabiting Earth. In the early 1970s, Crick and Orgel further speculated about the possibility that the production of living systems from molecules may have been a very rare event in the universe, but once it had developed it could be spread by intelligent life forms using space travel technology, a process they called "directed panspermia". In a retrospective article, Crick and Orgel noted that they had been unduly pessimistic about the chances of abiogenesis on Earth when they had assumed that some kind of self-replicating protein system was the molecular origin of life. In 1976, Crick addressed the origin of protein synthesis in a paper with Sydney Brenner, Aaron Klug, and George Pieczenik. In this paper, they speculate that code constraints on nucleotide sequences allow protein synthesis without the need for a ribosome.
=== 2016–present: Departure from Valve === Laidlaw announced his departure from Valve in January 2016. He said the primary reason for his departure was his age, and that he planned to return to writing stories. He felt he was becoming a "negative force" at Valve and hampering the creative process, saying: "I think at some point you need to let the people who are the fans and the creators who've come in because of what they learned from you maybe, and let them have that. We didn't need me going, 'Well, the G-Man wouldn't do that in my day.'" Laidlaw also tired of the FPS genre and of solving storytelling problems in a Half-Life-style narrative. He said he had "always hoped that we'd stumble into a more expansive vocabulary or grammar for storytelling within the FPS medium, one that would let you do more than shoot or push buttons, or push crates". On August 25, 2017, Laidlaw published a short story, "Epistle 3", describing it as "a snapshot of a dream I had many years ago". Journalists interpreted it as a summary of what could have been the plot for Half-Life 2: Episode Three. Laidlaw denied this, saying "all the real story development can only happen in the crucible of developing the game". In 2023, Laidlaw said he regretted publishing the story. He said he had been "deranged" and "completely out of touch" at the time, and that it had created problems for his former colleagues at Valve. In 2020, Valve released the VR game Half-Life: Alyx.
Sources: en.wikipedia.org
The dry powder is more stable during transport and storage than a solution. It also allows a known amount of material to be reconstituted at a chosen concentration.
Most certificates state a percentage derived from chromatographic peak area, alongside a mass confirmation. The exact criteria and acceptance thresholds vary between laboratories.
Dry powder is kept frozen or refrigerated and protected from light and moisture. Solutions are handled cold and used promptly to limit degradation.
The lyophilized powder is generally held at minus twenty degrees Celsius or below, away from light and moisture. Reconstituted solutions are typically refrigerated and used quickly. These practices derive from general peptide handling rather than a formal stability study.